INBRAIN Neuroelectronics, a Graphene Flagship spin-off, has developed an intelligent graphene-based neural implant for personalised neurological therapy in brain disorders.
INBRAIN Neuroelectronics’ work lies at...
Drs Kei Kanie and Ryuji Kato from Nagoya University are trying to break open the data-driven cell culture process development concept to ensure that the future of cell manufacturing will promise quality cell therapy products.
Interview with Dr Axel Gräwingholt, Clinical Co-Chair of the Guidelines Development Group (GDG) at the European Commission Initiative on Breast Cancer and AI
EIT Digital CEO, Willem Jonker, spoke to Clifford Holt, International Editor at The Innovation Platform, about the issues of digital sovereignty and Artificial Intelligence,...
Researchers from Purdue University, USA, have combined machine learning and tandem mass spectrometry to improve the flow of information in drug development.
Tandem mass spectrometry...
A recent research paper, published in Statistics in Biopharmaceutical Research, describes how advances in machine learning can provide an opportunity for researchers to create...
Undiscovered European AI biotech company Aladdin Healthcare Technologies continues to build novel technologies and achieve new milestones to combat age-related disease.
Aladdin Healthcare Technologies is...
The Innovation Platform spoke to DIGITALEUROPE’s Director General, Cecilia Bonefeld-Dahl, about Artificial Intelligence's (AI) role in assisting Europe's recovery from COVID-19.
Artificial intelligence (AI) is...
Aladdin Healthcare Technologies has developed a fully automated deep learning process for the detection of COVID-19 infection. The technology can prevent the false diagnoses...
Neuromorphic technology are rapidly advancing across Europe and are poised to help accelerate the AI revolution.
By taking loose inspiration from the brain, artificial neural...